Vanguard Industrials ETF(VIS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VIS Vanguard Industrials ETF

休市中 12-12 16:00:00 EST

302.20

-3.27

-1.07%

盘后302.20

+0.000.00%

17:19 EST

最高306.49	最低301.42	成交量3.88万
今开306.49	昨收305.47	日振幅1.66%
总市值64.27亿	流通市值64.21亿	总股本2,127万
成交额1,179万	换手率0.18%	流通股本2,125万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VIS","market":"US","secType":"STK","nameCN":"Vanguard Industrials ETF","latestPrice":302.2,"timestamp":1765573200000,"preClose":305.47,"halted":0,"volume":38846,"hourTrading":{"tag":"盘后","latestPrice":302.2,"preClose":302.2,"latestTime":"17:19 EST","volume":180,"amount":54438.87,"timestamp":1765577964104},"delay":0,"floatShares":21247060,"shares":21267060,"eps":42.69867,"marketStatus":"休市中","change":-3.27,"latestTime":"12-12 16:00:00 EST","open":306.49,"high":306.49,"low":301.42,"amount":11789921.04552,"amplitude":0.016597,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":42.69867,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":305.47,"sharesOutstanding":21267060,"nav":305.41,"aum":6495172794.6,"dividendRate":0.010513,"bidAskSpread":0.000698,"preHourTrading":{"tag":"盘前","latestPrice":308.42,"preClose":305.47,"latestTime":"09:06 EST","volume":26,"amount":8010.39772,"timestamp":1765548414937},"postHourTrading":{"tag":"盘后","latestPrice":302.2,"preClose":302.2,"latestTime":"17:19 EST","volume":180,"amount":54438.87,"timestamp":1765577964104},"volumeRatio":0.9014183810570279,"impliedVol":0.1027,"impliedVolPercentile":0.032},"requestUrl":"/m/hq/s/VIS/tweets","defaultTab":"tweets","newsList":[{"id":"2579686441","title":"云顶新耀(01952)引进眼科双抗药物VIS-101 切入400亿美元眼科蓝海市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2579686441","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579686441?lang=zh_cn&edition=full","pubTime":"2025-10-30 10:28","pubTimestamp":1761791308,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月30日，港股创新药企云顶新耀宣布，与Visara签订协议，获得独家许可，在大中华区、新加坡、韩国及若干东南亚国家进行临床开发、生产和商业化VIS-101。此举是云顶新耀在肾科和自身免疫等蓝海领域布局后，依托“双轮驱动”战略进军眼科治疗领域的关键一步，标志着公司正式切入百亿级眼科蓝海市场。眼科药物市场近年来增长迅猛。数据显示，2024年全球抗VEGF眼科药物市场规模约为230亿美元，预计到2030年将突破400亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","BK4588","VIS","BK1574","BK1161","BK1583","BK4585"],"gpt_icon":0},{"id":"2579632153","title":"云顶新耀(01952)与VISARA订立协议 于大中华区及其他亚洲市场开发及商业化VIS -101","url":"https://stock-news.laohu8.com/highlight/detail?id=2579632153","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579632153?lang=zh_cn&edition=full","pubTime":"2025-10-30 07:09","pubTimestamp":1761779358,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀 公布，于2025年10月28日，该公司与Visara,Inc.订立协议，据此Visara不可撤销地授予公司独家许可，于大中华区、新加坡、南韩及若干东南亚国家开发、生产及商业化VIS-101，其为一种新型双功能生物制剂，针对VEGF-A与ANG-2，其疗效较第一代治疗更为显著，可望为湿性年龄相关性黄斑部病变、糖尿病性黄斑部水肿及视网膜静脉阻塞患者提供更持久的治疗效益。VIS-101亦令公司能够扩展到眼科这一个具有竞争力且存在大量未满足的医疗需要的领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIS","BK1574","01952","BK4585","BK1583","BK4588","BK1161"],"gpt_icon":0},{"id":"2518062214","title":"TrendForce集邦咨询：4Q24前十大晶圆代工业者合计营收季增近10%再创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2518062214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518062214?lang=zh_cn&edition=full","pubTime":"2025-03-10 17:17","pubTimestamp":1741598249,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据TrendForce集邦咨询最新调查，2024年第四季全球晶圆代工产业呈两极化发展，先进制程受惠于AI Server等新兴应用增长，以及新款旗舰级智能手机AP和PC新平台备货周期延续，带动高价晶圆出货增长，抵销成熟制程需求趋缓带来的冲击，前十大晶圆代工业者合计营收季增近10%，达384.8亿美元，再创新高。综合上述原因，HuaHong Group营收季增6.1%，达10.4亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4526","BK4585","PSMC","BK4554","UMC","BK4141","BK4588","BK4605","VIS"],"gpt_icon":0},{"id":"2482487681","title":"晶丰明源：收购易冲补全产品矩阵，营收规模挺进行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2482487681","media":"集微网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482487681?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:16","pubTimestamp":1731032212,"startTime":"0","endTime":"0","summary":"随着并购六条、科创板八条的出台，整个半导体行业对并购整合充满期待。当前市面上有一部分由于门槛太高还未来得及上市的“遗珠”，正积极找寻同业巨头之间强强联合的机会，以实现双方实力的共同补强。对企业来说，充分把握中央及地方监管机构支持上市公司并购重组、加强产业整合的政策导向，紧握市场机遇，并结合自身实际情...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/Ov5mos47bOR9M8z20cWyKyu9EgQPwntmRN3SFnuG73YfcAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Ov5mos47bOR9M8z20cWyKyu9EgQPwntmRN3SFnuG73YfcAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241108A02MG100","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241108A02MG100","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4585","VIS","BK4588","WPC","BK4160"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.0388},{"period":"6month","weight":0.1181},{"period":"1year","weight":0.1293},{"period":"ytd","weight":0.1879}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.47619,"avgChangeRate":0.000166},{"month":2,"riseRate":0.619048,"avgChangeRate":0.009571},{"month":3,"riseRate":0.619048,"avgChangeRate":0.009272},{"month":4,"riseRate":0.619048,"avgChangeRate":0.016652},{"month":5,"riseRate":0.666667,"avgChangeRate":0.006473},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.005312},{"month":7,"riseRate":0.809524,"avgChangeRate":0.025703},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.003249},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.00262},{"month":10,"riseRate":0.636364,"avgChangeRate":0.00927},{"month":11,"riseRate":0.818182,"avgChangeRate":0.037444},{"month":12,"riseRate":0.545455,"avgChangeRate":-0.000908}],"exchange":"ARCA","name":"Vanguard Industrials ETF","nameEN":"Vanguard Industrials ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vanguard Industrials ETF(VIS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vanguard Industrials ETF(VIS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vanguard Industrials ETF,VIS,Vanguard Industrials ETF股票,Vanguard Industrials ETF股票老虎,Vanguard Industrials ETF股票老虎国际,Vanguard Industrials ETF行情,Vanguard Industrials ETF股票行情,Vanguard Industrials ETF股价,Vanguard Industrials ETF股市,Vanguard Industrials ETF股票价格,Vanguard Industrials ETF股票交易,Vanguard Industrials ETF股票购买,Vanguard Industrials ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vanguard Industrials ETF(VIS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vanguard Industrials ETF(VIS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}